Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1977 2
1978 4
1979 4
1980 5
1981 3
1982 4
1983 7
1984 7
1985 5
1986 9
1987 9
1988 11
1989 10
1990 9
1991 9
1992 10
1993 15
1994 22
1995 23
1996 18
1997 31
1998 26
1999 19
2000 18
2001 27
2002 22
2003 12
2004 12
2005 5
2006 7
2007 4
2008 3
2009 4
2010 8
2011 5
2012 8
2013 5
2014 2
2015 4
2016 3
2017 5
2018 3
2019 4
2020 3
2021 2
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H. Thomas DA, et al. Among authors: cabanillas f. Cancer. 2006 Apr 1;106(7):1569-80. doi: 10.1002/cncr.21776. Cancer. 2006. PMID: 16502413 Free article. Clinical Trial.
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Cheson BD, et al. Among authors: cabanillas f. J Clin Oncol. 1999 Apr;17(4):1244. doi: 10.1200/JCO.1999.17.4.1244. J Clin Oncol. 1999. PMID: 10561185 Review.
Mantle-cell lymphoma.
Barista I, Romaguera JE, Cabanillas F. Barista I, et al. Among authors: cabanillas f. Lancet Oncol. 2001 Mar;2(3):141-8. doi: 10.1016/S1470-2045(00)00255-2. Lancet Oncol. 2001. PMID: 11902564 Review.
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Free article. Clinical Trial.
Asymptomatic Waldenstrom's macroglobulinemia.
Alexanian R, Weber D, Delasalle K, Cabanillas F, Dimopoulos M. Alexanian R, et al. Among authors: cabanillas f. Semin Oncol. 2003 Apr;30(2):206-10. doi: 10.1053/sonc.2003.50051. Semin Oncol. 2003. PMID: 12720137
Check this checkpoint inhibitor in lymphoma.
Cabanillas F, Rivera N. Cabanillas F, et al. Blood. 2017 Jul 20;130(3):234-235. doi: 10.1182/blood-2017-05-786293. Blood. 2017. PMID: 28729332 Free article. No abstract available.
Non-Hodgkin's lymphoma: the old and the new.
Cabanillas F. Cabanillas F. Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S87-90. doi: 10.1016/j.clml.2011.03.029. Epub 2011 Apr 28. Clin Lymphoma Myeloma Leuk. 2011. PMID: 22035756 Review.
429 results